Prostate Cancer - Results from #23040

Influence of serum prostate-specific antigen (PSA) level, prostate volume, and PSA density on prostate cancer detection with contrast-enhanced sonography using contrast-tuned imaging technology - Abstract June 5, 2013

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer - Abstract June 5, 2013

Salvage CT-guided transgluteal cryoablation for locally recurrent prostate cancer: Initial experiences - Abstract June 5, 2013

ASCO 2013 - Poster: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone June 5, 2013

ASCO 2013 - Podcast: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone June 5, 2013

ASCO 2013 - Podcast: A discussion of the implementation and sequencing of treatment with sipuleucel-T for men with metastatic castration-resistant prostate cancer (mCRPC): Key messages from poster presentations at ASCO June 5, 2013

The establishment of K-CaP (the multicenter Korean Prostate Cancer Database) - Abstract June 4, 2013

Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer? - Abstract June 4, 2013

Increasing prostate-specific antigen levels differently influence prostate cancer detection rates of two different 12-core prostate biopsy schemes - Abstract June 4, 2013

Diffusion-weighted magnetic resonance imaging in the prostate transition zone: Histopathological validation using magnetic resonance-guided biopsy specimens - Abstract June 4, 2013

ASCO 2013 - Podcast: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC) June 4, 2013

Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer - Abstract June 4, 2013

Salvage treatment in prostate cancer: A clinical approach - Abstract June 4, 2013

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: Secondary analysis of radiation therapy oncology group (RTOG) 8610 - Abstract June 4, 2013

Paradoxical metastatic progression following 3months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer - Abstract June 4, 2013

Active surveillance in low-risk prostate cancer. Patient acceptance and results - Abstract June 4, 2013

Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study - Abstract June 4, 2013

ASCO 2013 - Poster: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data June 3, 2013

Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement - Abstract June 3, 2013

Critical evaluation of MRI-targeted TRUS-guided transperineal fusion biopsy for detection of prostate cancer - Abstract June 3, 2013

Page 1153 of 1436